Diltiazem inhibits breast cancer metastasis via mediating growth differentiation factor 15 and epithelial-mesenchymal transition

Migration and metastasis commonly happen to triple-negative breast cancer (TNBC) patients with advanced diseases. In many studies, it has been suggested that epithelial-mesenchymal transition (EMT) is one of the key mechanisms triggering cancer metastasis. Accumulating evidence has proven that calci...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yen-Chang, Wu, Chen-Teng, Chen, Jia-Hong, Tsai, Cheng-Fang, Wu, Chen-Yun, Chang, Pei-Chun, Yeh, Wei-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376069/
https://www.ncbi.nlm.nih.gov/pubmed/35963873
http://dx.doi.org/10.1038/s41389-022-00423-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376069/
https://www.ncbi.nlm.nih.gov/pubmed/35963873
http://dx.doi.org/10.1038/s41389-022-00423-5

Ejemplares similares